| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |